SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-21-000156
Filing Date
2021-02-03
Accepted
2021-02-03 17:57:54
Documents
1
Period of Report
2021-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6581
  Complete submission text file 0001123292-21-000156.txt   9030
Mailing Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521
Business Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O SILVER POINT CAPITAL L.P. TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830
Business Address
MULE EDWARD A (Reporting) CIK: 0001029625 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 21587661

Mailing Address TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830
Business Address TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830 (203) 542-4000
Silver Point Capital L.P. (Reporting) CIK: 0001332784 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 21587659

Mailing Address C/O SILVER POINT CAPITAL L.P. TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830
Business Address
O'Shea Robert J (Reporting) CIK: 0001382617 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 21587660